As of Apr 25
| -0.0142 / -4.07%|
The 1 analysts offering 12-month price forecasts for Rosetta Genomics Ltd have a median target of 0.60, with a high estimate of 0.60 and a low estimate of 0.60. The median estimate represents a +79.05% increase from the last price of 0.34.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.